The Application of Enhanced Recovery After Surgery (ERAS) for Cardiovascular Surgery in Adult

Launched by YAN FUXIA · Jun 12, 2023

Keywords

ClinConnect Summary

This clinical trial is studying a new approach called Enhanced Recovery After Surgery (ERAS) for adults who are having heart surgery that requires a heart-lung machine. The goal of ERAS is to help patients recover faster and have fewer complications after surgery. The trial compares the ERAS method, which includes things like pre-surgery education, special drinks before surgery, better pain management, and quicker recovery practices, to the usual care patients typically receive. Researchers will look at how many patients experience serious problems after surgery, how long they stay in the hospital or intensive care unit (ICU), and how satisfied they are with their recovery.

To be eligible for this trial, participants need to be between 18 and 80 years old and scheduled for elective heart surgery that involves cardiopulmonary bypass. However, there are some important exclusions, such as patients with severe health issues or those using certain medications. If you or a loved one meets the criteria and decides to participate, you can expect a focus on improving recovery and reducing complications, while also contributing to valuable research that could benefit future patients.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients aged 18 to 80 years
• • Patients awaiting elective cardiac surgery with cardiopulmonary bypass (CPB)
• Exclusion Criteria:
• • American Society of Anesthesiologists (ASA) class is above class V
• • Patients with cardiac assist device or mechanical ventilation
• • The ejection fraction of patients is less than 30%
• • Patients with morbid obesity
• • Patients with severe obstructive sleep apnea-hypopnea syndrome (OSAHS)
• • Patients with severe pulmonary disease, including severe chronic obstructive pulmonary disease (COPD) or respiratory failure
• • Patients with severe liver or renal dysfunction, including severe acute or chronic renal dysfunction need renal replacement therapy, and acute or chronic liver failure need artificial liver therapy
• • Patients with long-term opioid or sedative utilization
• • Patients with a history of alcohol or cigarette abuse
• • Patients with long-term hormone therapy
• • An international normalized ratio \> 2.0
• • Patients with severe malnutrition
• • Mental or legal disability
• • Current enrollment in another clinical trial
• • Patients' refusal or low adherence